Paris, France — 25 September 2023 — Genèse Labs has launched RG60® HA Body Filler, the company’s first in-house product, together with completion of the RG60™ trademark registration — an injectable dermal filler developed on French biotechnology and designed to refine body contours and correct volume without surgery.

RG60® is designed for non-surgical body contouring across a broad range of areas, including silhouette refinement, improvement of breast volume and firmness, hip volume augmentation and curve definition, refinement of the calf line, intimate-area improvement, and the smoothing of skin-surface irregularities. The product is supplied ready for injection in sterile single-use vials.

The principal ingredient is cross-linked hyaluronic acid — a substance that occurs naturally in human connective tissue and can bind several hundred times its own weight in water. Cross-linking joins the hyaluronic-acid chains, increasing resistance to breakdown in the body and conferring the viscoelasticity and longevity required of a filler. 

A single RG60® treatment provides 12–24 months of duration, working in harmony with human physiology and breaking down gradually in step with the body’s natural metabolic cycle, which makes repeat treatment straightforward. Duration typically accumulates across successive treatments, and the recommended plan is a corrective session two to three months after the first, followed by a further treatment between six and twenty-four months later. [Detailed session protocols are reserved for professional catalogue materials.

The RG60™ trademark registration, completed simultaneously with the launch, reflects a deliberate approach to intellectual property. For a company entering markets across several continents, securing trademark protection at launch prevents pre-emptive third-party registration in target regions and establishes a foundation of brand equity — a practice since applied consistently to Proluma™, Citrus Bottle™ and Exoluma™.

RG60® established the naming system and technical architecture that would later expand. The following year the RG series grew to include RG80, RG100 and RG55S, giving practitioners a graduated set of options within a single product family.

Genèse Labs is a Paris-founded aesthetic company dedicated to science-based, regulatory-led product development across the fast-growing fields of body contouring, collagen biostimulation, and regenerative skincare. Since its foundation in 2019, the company has built its portfolio — including RG60®, Proluma™, Citrus Bottle™ and the Exoluma™ series — on three principles: scientifically verifiable formulations, regulatory compliance in every market entered, and continuous engagement with the international clinical and academic community. Genèse Labs partners with dermatologists, aesthetic physicians, and distributors worldwide to advance the standard of modern aesthetic medicine. For more information: www.geneselabs.net.